We serve D-Asparagine Monohydrate CAS:5794-24-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
D-Asparagine Monohydrate
CAS RN:5794-24-1
| Solubility in water | Colorless & clear (c=2) |
| Specific rotation (20 °C) | -33.5°～-36.5°(c= 10, 6M-HCl) |
| Loss on drying | 11.5%～12.5% |
| Residue on ignition (as sulfate) | Not more than 0.1% |
| Chloride (Cl) | Not more than 0.03% |
| Sulfate (SO4) | Not more than 0.03% |
| Heavy metals (as Pb) | Not more than 10ppm |
| Iron (Fe) | Not more than 10ppm |
| Ammonium (NH4) | Not more than 0.02% |
| Arsenic (As2O3) | Not more than 1ppm |
| Other amino acid (D-Asp) | Not more than 1.0% by T.L.C (The spotted amount, 20 mg) |
| Assay (as anhydrous) | 98.5%～101.0% |
| L-Isomer | Not more than 0.5% |
Contact us for information like D-Asparagine Monohydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R)-2,4-diamino-4-oxobutanoic acid,hydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R)-2,4-diamino-4-oxobutanoic acid,hydrate Use and application,D-Asparagine Monohydrate technical grade,usp/ep/jp grade.
Related News: Wuhan’s local transport networks – including bus, subway and ferries – were suspended from 10am on 23 January, and airport and train stations closed to outgoing passengers.methyl 3-[3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-hydroxybenzoate manufacturer Wuhan’s local transport networks – including bus, subway and ferries – were suspended from 10am on 23 January, and airport and train stations closed to outgoing passengers.5-METHYLQUINOXALINE supplier The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.2-(5-Chloro-2-Benzotriazolyl)-6-Tert-Butyl-p-Cresol vendor “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December.
